Health
Antibody Cocktail Seems to Prevent COVID-19 Spread – Medscape
The antibody cocktail casirivimab and imdevimab may be an option to ward off infection, but the study didn’t quite reach statistical significance.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A one-time injection of the monoclonal antibody cocktail casirivimab with imdevimab (REGEN-COV), taken within 72 hours of a household member’s diagnosis with SARS-CoV-2, prevented 100% of COVID-19 illness, 100% of high SARS-CoV-2 viral loads, and cut length of asymptomatic infection to 1 week.
“It’s fantastic news,” said Rajesh Gandhi, MD, an infectious disease physician at Massachusetts General…
-
Business18 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News23 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Business18 hours agoWhy this ASX All Ords stock could return 40% in a year
-
Noosa News17 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane